v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Sales, net of returns and allowances $ 2,509,717 $ 3,028,545 $ 4,691,451 $ 8,688,423
Cost of sales 6,642,549 6,557,358 21,386,676 20,312,854
Gross loss (4,132,832) (3,528,813) (16,695,225) (11,624,431)
Operating expenses        
Selling, general and administrative 7,722,014 11,756,291 33,883,845 40,448,651
Research and development 2,313,423 5,771,588 7,834,113 18,056,182
Total operating expenses 10,035,437 17,527,879 41,717,958 58,504,833
Loss from operations (14,168,269) (21,056,692) (58,413,183) (70,129,264)
Interest income (expense), net (8,317,813) 410,980 (15,109,136) 1,466,839
Fair value adjustment (loss) on warrants (2,649,477) 0 (7,089,027) 0
Other income (loss) 0 (10,000,000) 0 (10,000,000)
Loss before benefit for income taxes (25,135,559) (30,645,712) (80,611,346) (78,662,425)
Benefit for income taxes 0 0 0 0
Net loss $ (25,135,559) $ (30,645,712) $ (80,611,346) $ (78,662,425)
Net loss per share of common stock        
Basic (in usd per share) [1] $ (0.98) $ (2.84) $ (4.06) $ (8.29)
Diluted (in usd per share) [1] $ (0.98) $ (2.84) $ (4.06) $ (8.29)
Weighted average shares used in computing net loss per share of common stock        
Basic (in shares) [1] 25,589,725 10,793,926 19,879,290 9,487,842
Diluted (in shares) [1] 25,589,725 10,793,926 19,879,290 9,487,842
[1] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.

Source